CAS 104291-17-0

Formule : C11H13ClN4O3

InChI : InChI=1S/C11H13ClN4O3/c12-9-5-1-2-16(10(5)15-11(13)14-9)8-3-6(18)7(4-17)19-8/h1-2,6-8,17-18H,3-4H2,(H2,13,14,15)/t6-,7+,8-/m0/s1

Code InChI : BZICGWWJWKJNCN-RNJXMRFFSA-N

SMILES : C1[C@@H]([C@H](O[C@@H]1N2C=CC3=C2N=C(N=C3Cl)N)CO)O

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

CAS : 104291-17-0

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

Formule : C₁₁H₁₃ClN₄O₃

Degré de pureté : >95%

Masse moléculaire : 284.7

Ref: 54-OR1064080

7-Deaza-4-Cl-2’-dG

CAS : 104291-17-0

Formule : C₁₁H₁₃ClN₄O₃

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 284.6989

Ref: IN-DA008SL4

7-Deaza-4-Cl-2'-deoxyguanosine

CAS : 104291-17-0

7-Deaza-4-Cl-2'-deoxyguanosine is a novel antiviral drug that has been synthesized in the laboratory. It is an analogue of deoxyguanosine, a nucleoside that is found in DNA and RNA. 7-Deaza-4-Cl-2'-deoxyguanosine has anti cancer properties because it inhibits the synthesis of DNA by inhibiting the activity of ribonucleoside reductase, an enzyme that converts ribonucleosides to deoxyribonucleosides. This drug has been shown to have potent anticancer activity against human lung cancer cells and mouse leukemia cells.

Formule : C₁₁H₁₃ClN₄O₃

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 284.7 g/mol

Ref: 3D-ND57492

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

CAS : 104291-17-0

Degré de pureté : 95+%

Masse moléculaire : 284.7000122

Ref: 10-F869453

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

CAS : 104291-17-0

(2R,3S,5R)-5-(2-Amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

Formule : C₁₁H₁₃ClN₄O₃

Degré de pureté : 95+%

Masse moléculaire : 284.7

Ref: IN-DG291285